Skip to Content

DAIICHI SANKYO -About the News Report

[ENP Newswire]

TOKYO, Japan - Today, some media in Japan reported that Daiichi Sankyo Co., Ltd. and GlaxoSmithKline plc will establish a vaccine-related joint venture company .

Our company consider vaccines to be a core business segment, and to strengthen our operations we constantly evaluate a wide range of strategic development opportunities.

However, today's media reports are not based on any official announcement by the Daiichi Sankyo Group.

[Editorial queries for this story should be sent to]

((Comments on this story may be sent to


Posted: December 2011